India, Sept. 1 -- Sun Pharmaceutical Industries has entered into an agreement with the US government to improve access to affordable medicines for American patients, the company said in a regulatory filing on Tuesday.
Under the agreement, signed at a ceremony at the White House, Sun Pharma will extend 'Most Favoured Nation' (MFN) pricing to state Medicaid programmes in the US.
The pricing commitment will also cover the company's future innovative medicine launches in the US, Sun Pharma said.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....